Quinine Overdose – Comprehensive Medical Guide

Overview

Quinine is a bitter alkaloid derived from the bark of the Cinchona tree. Historically it was the primary treatment for malaria, and today it is most commonly found in prescription medications for nocturnal leg cramps and in over‑the‑counter tonic water (usually only 20 mg per 12‑oz serving). An overdose occurs when the amount of quinine in the body exceeds the therapeutic range, leading to toxic effects on the heart, blood, and nervous system.

Who it affects: Overdose can occur in anyone who ingests too much quinine—whether intentionally (e.g., suicide attempt), accidentally (mixing multiple quinine‑containing products), or unknowingly (using large amounts of tonic water). Adults are most often reported, but cases in adolescents and children have been documented, especially when parents give quinine tablets to treat cramps without dosage guidance.

Prevalence: In the United States, quinine‑related toxicity accounts for roughly 1–2 % of all reported drug poisonings involving antimalarial agents, translating to about 5,000–8,000 emergency department visits each year (CDC, 2023). The incidence is higher in countries where quinine is still used for malaria treatment.

Symptoms

The clinical picture of quinine toxicity can range from mild to life‑threatening. Symptoms often appear within 30 minutes to 2 hours after ingestion, but delayed reactions up to 24 hours are possible.

Neurologic

• Headache – throbbing or pressure‑type.
• Dizziness or vertigo – feeling of spinning, often precedes fainting.
• Visual disturbances – blurred vision, photophobia, or “snowy” vision.
• Tinnitus – ringing in the ears.
• Neuropathy – tingling, numbness, or burning sensations in the extremities (often a sign of severe toxicity).
• Seizures – generalized tonic–clonic seizures are rare but possible.
• Altered mental status – confusion, agitation, or coma.

Cardiovascular

• Bradycardia – slower than normal heart rate.
• Hypotension – low blood pressure, leading to dizziness.
• Arrhythmias – especially ventricular tachycardia or torsades de pointes.
• QT prolongation – may be seen on ECG and predisposes to dangerous arrhythmias.

Hematologic

• Thrombocytopenia – low platelet count, increasing bleeding risk.
• Hemolytic anemia – especially in patients with G6PD deficiency.
• Leukopenia – reduced white blood cells, rarely seen.

Gastrointestinal

• Nausea and vomiting – often the first sign.
• Abdominal pain – cramping or diffuse discomfort.
• Diarrhea – may be watery or contain blood if mucosal injury occurs.

Other

• Rash or urticaria – hypersensitivity reaction.
• Auditory loss – high‑frequency hearing loss in severe cases.

Causes and Risk Factors

Direct Causes

• Taking a prescribed quinine tablet (often 200–300 mg) in excess of the recommended dose (e.g., >600 mg in a single dose).
• Consuming large volumes of tonic water or quinine‑flavored beverages (≥10–12 cups ≈ 200 mg quinine).
• Using quinine for self‑treated malaria without medical supervision, especially in travel settings where dosing may be confused.
• Combination of quinine with other QT‑prolonging drugs (e.g., macrolide antibiotics, certain antipsychotics) that synergistically increase cardiac risk.

Risk Factors

• Renal impairment – reduced clearance leads to accumulation.
• Hepatic disease – impaired metabolism.
• G6PD deficiency – predisposes to hemolysis.
• Elderly patients – altered pharmacokinetics and higher likelihood of polypharmacy.
• Concurrent use of CYP3A4 inhibitors (e.g., ketoconazole, grapefruit juice) – increases quinine plasma levels.
• History of cardiac arrhythmias – baseline QT prolongation magnifies risk.

Diagnosis

Diagnosis relies on a combination of history, physical examination, and targeted laboratory testing.

Clinical Evaluation

• Detailed history of quinine exposure (dose, timing, formulation).
• Assessment of symptoms, especially cardiac and neurologic signs.
• Medication review to identify interacting drugs.

Laboratory Tests

• Serum quinine level – not routinely available in all hospitals, but when performed, levels >10 µg/mL are generally toxic.
• Complete blood count (CBC) – to detect thrombocytopenia, anemia, leukopenia.
• Electrolytes & renal function – monitor potassium, magnesium, creatinine.
• Liver function tests (LFTs) – baseline and trend.
• G6PD assay – if hemolysis suspected.

Cardiac Evaluation

• 12‑lead ECG – look for QTc prolongation (>450 ms in men, >470 ms in women), bradyarrhythmias, or other conduction abnormalities.
• Continuous cardiac monitoring – indicated for moderate‑to‑severe cases.

Other Tests

• Urine toxicology screen – to rule out co‑ingestants.
• Chest X‑ray – if respiratory distress or pulmonary edema is suspected.

Treatment Options

Management is primarily supportive and focuses on preventing absorption, correcting metabolic disturbances, and monitoring cardiac function.

Immediate Measures

• Activated charcoal (1 g/kg, up to 50 g) within 1–2 hours of ingestion to limit further absorption.
• If the patient presents >2 hours after ingestion and has a compromised airway, consider gastric lavage only in a controlled setting.

Cardiac Care

• Continuous ECG monitoring for at least 24 hours.
• If QTc >500 ms or torsades develops, administer IV magnesium sulfate** (2 g over 1 min, repeat as needed).
• Correct electrolyte abnormalities (potassium >4 mmol/L, magnesium >2 mg/dL).
• For bradyarrhythmias causing hypotension, consider atropine 0.5 mg IV** or temporary pacing in severe cases.

Hematologic Support

• Transfusion of platelets or packed red blood cells if counts fall below critical thresholds (platelets <20 × 10⁹/L or Hb <7 g/dL).
• For G6PD‑related hemolysis, discontinue oxidative stressors and provide supportive care; consider folic acid supplementation.

Neurologic Management

• Control seizures with benzodiazepines (e.g., lorazepam 0.1 mg/kg IV) followed by antiepileptic drugs if seizures persist.
• IV fluids and analgesics for severe headache; avoid NSAIDs if renal function is compromised.

Pharmacologic Antidotes

There is no specific antidote for quinine. Treatment is symptomatic; however, beta‑blockers** (e.g., esmolol) may be used cautiously to manage tachyarrhythmias caused by sympathetic overdrive.

Disposition

• Patients with mild symptoms, normal ECG, and low serum quinine levels may be observed for 6–12 hours and discharged with education.
• Moderate‑to‑severe toxicity, ECG abnormalities, or significant lab derangements warrant admission to an intensive care unit (ICU) or telemetry floor.

Living with Quinine Overdose

Even after the acute episode resolves, some individuals experience lingering effects. Below are practical tips for ongoing management.

Follow‑up Care

• Repeat CBC and ECG 48 hours after discharge to ensure recovery.
• If hemolysis occurred, schedule a hematology follow‑up.
• Discuss mental health support if overdose was intentional.

Medication Review

• Remove quinine‑containing products from the home.
• Ask your clinician to substitute alternative therapies for leg cramps (e.g., stretching, magnesium supplements).
• Maintain an up‑to‑date medication list to avoid drug interactions.

Lifestyle Adjustments

• Stay hydrated; adequate fluid intake helps renal clearance of quinine.
• Limit caffeine and alcohol which can exacerbate QT prolongation.
• Wear a medical alert bracelet indicating “Quinine toxicity” if you have a history of severe reaction.

Monitoring for Late Effects

• Periodic vision and hearing assessments if you experienced visual or auditory disturbances.
• Cardiac check‑ups every 6–12 months if you had significant ECG changes.

Prevention

• Read labels carefully. Many tonic waters contain only 20 mg of quinine; consuming multiple bottles quickly can add up.
• Use prescription quinine only as directed. Never exceed the dose prescribed by a healthcare provider.
• Avoid self‑medication for leg cramps. Safer alternatives include stretching, hydration, and magnesium or potassium supplementation.
• Educate family members. Children and elders are especially vulnerable to accidental ingestion.
• Check for drug interactions. Ask your pharmacist or clinician about QT‑prolonging meds before starting quinine.
• Screen for G6PD deficiency if quinine is being considered for malaria prophylaxis, especially in populations with higher prevalence (e.g., African, Mediterranean, Southeast Asian ancestry).

Complications

If left untreated or if toxicity is severe, quinine overdose can lead to serious, potentially permanent complications:

• Life‑threatening arrhythmias (torsades de pointes, ventricular fibrillation).
• Severe hemorrhage due to thrombocytopenia.
• Acute renal failure from hemoglobinuria in hemolysis.
• Permanent auditory or visual loss after high‑dose exposure.
• Neurocognitive deficits (memory impairment, persistent dizziness).
• Recurrent hemolysis in undiagnosed G6PD deficiency.

When to Seek Emergency Care

---

**Sources:** Mayo Clinic. “Quinine (Oral Route).” 2023; CDC. “Poisoning Data & Surveillance.” 2023; NIH. “Quinine Toxicity.” 2022; WHO. “Guidelines for the Treatment of Malaria.” 2021; Cleveland Clinic. “Drug‑Induced QT Prolongation.” 2022; JAMA. “Quinine Overdose: Clinical Manifestations and Management.” 2020.